Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Benchmarks help you measure performance. This intro explains which indices serve as benchmarks and how investors use them to compare risk and return.
20,611 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Six ETFs now cover the entire grid-resilience thesis, from hardware and software to infrastructure and energy metals,...
Fluence Energy surged nearly 100% in a week on big contract wins and a growing backlog. A quartet of AI-exposed energ...
When great growth ideas stumble, the long-term case often remains intact. This piece examines two names that have fal...
Astera Labs’ stock jumped after management laid out a firm timetable for a new switch and signaled growing opportunit...
Bitcoin stabilizes around $77,000 as two altcoins post double-digit gains from these, signaling renewed momentum and ...
Arm Holdings has surged 104% year-to-date, with the AI pivot and AGI CPU driving demand. Smart money sits near a spec...
Retirees cling to a low-cost dividend ETF that advisors often push, yet most seniors can’t recall the ticker. This re...
Discover how terra innovatum (nklr) 2025 shapes investor strategy. This guide breaks down growth drivers, risks, and ...
SUI has introduced gasless stablecoin transfers, eliminating on-chain fees for supported assets and expanding enterpr...
A new northwestern mutual 2025 study shows most Americans have no will, with Gen X and Baby Boomers lagging in estate...
Star Bulk reported a solid Q1 2026, reflecting steady demand for commodities and a modern fleet. This article unpacks...